1. Home
  2. SEER vs OKYO Comparison

SEER vs OKYO Comparison

Compare SEER & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seer Inc.

SEER

Seer Inc.

HOLD

Current Price

$1.79

Market Cap

97.3M

Sector

Health Care

ML Signal

HOLD

Logo OKYO Pharma Limited

OKYO

OKYO Pharma Limited

HOLD

Current Price

$1.65

Market Cap

83.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEER
OKYO
Founded
2017
2007
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.3M
83.4M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
SEER
OKYO
Price
$1.79
$1.65
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.33
AVG Volume (30 Days)
364.2K
41.6K
Earning Date
05-13-2026
07-18-2025
Dividend Yield
N/A
N/A
EPS Growth
9.40
N/A
EPS
N/A
N/A
Revenue
$16,578,000.00
N/A
Revenue This Year
$2.14
N/A
Revenue Next Year
$25.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.99
N/A
52 Week Low
$1.65
$1.44
52 Week High
$2.41
$3.35

Technical Indicators

Market Signals
Indicator
SEER
OKYO
Relative Strength Index (RSI) 45.19 55.21
Support Level $1.76 $1.48
Resistance Level $1.84 $1.73
Average True Range (ATR) 0.07 0.06
MACD -0.01 0.01
Stochastic Oscillator 32.26 65.57

Price Performance

Historical Comparison
SEER
OKYO

About SEER Seer Inc.

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

Share on Social Networks: